Advisor Group Holdings, Inc. Logic Bio Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.35 - $0.74 $1,400 - $2,960	-4,000 Reduced 81.22%	925 $0
Q1 2022 May 04, 2022	BUY	$0.61 - $2.49 $101 - $413	166 Added 3.49%	4,925 $3,000
Q3 2021 Nov 05, 2021	BUY	$3.85 - $5.09 $1,925 - $2,545	500 Added 11.74%	4,759 $22,000
Q2 2021 Aug 02, 2021	BUY	$4.03 - $7.57 $15,753 - $29,591	3,909 Added 1116.86%	4,259 $19,000
Q1 2021 May 13, 2021	BUY	$6.8 - $9.16 $2,380 - $3,206	350 New	350 $3,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.